A detailed history of Legal & General Group PLC transactions in Generation Bio Co. stock. As of the latest transaction made, Legal & General Group PLC holds 3,919 shares of GBIO stock, worth $6,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,919
Previous 3,919 -0.0%
Holding current value
$6,035
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$3.65 - $6.9 $3,128 - $5,913
-857 Reduced 17.94%
3,919 $14,000
Q1 2023

May 15, 2023

SELL
$3.61 - $7.01 $56,572 - $109,853
-15,671 Reduced 76.64%
4,776 $20,000
Q4 2022

Feb 14, 2023

BUY
$3.66 - $6.77 $5,409 - $10,006
1,478 Added 7.79%
20,447 $80,000
Q3 2022

Nov 14, 2022

BUY
$4.68 - $8.34 $8,447 - $15,053
1,805 Added 10.52%
18,969 $100,000
Q2 2022

Aug 22, 2022

BUY
$4.87 - $9.41 $2,313 - $4,469
475 Added 2.85%
17,164 $113,000
Q1 2022

May 16, 2022

BUY
$4.16 - $7.76 $694 - $1,295
167 Added 1.01%
16,689 $123,000
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.43 $141,900 - $194,615
7,095 Added 75.26%
16,522 $414,000
Q2 2021

Aug 12, 2021

BUY
$24.34 - $38.34 $9,030 - $14,224
371 Added 4.1%
9,427 $254,000
Q1 2021

May 17, 2021

BUY
$24.74 - $40.2 $179,043 - $290,927
7,237 Added 397.86%
9,056 $257,000
Q4 2020

Feb 12, 2021

BUY
$21.68 - $51.61 $9,821 - $23,379
453 Added 33.16%
1,819 $52,000
Q3 2020

Nov 13, 2020

SELL
$18.07 - $31.84 $288,632 - $508,580
-15,973 Reduced 92.12%
1,366 $42,000
Q2 2020

Aug 14, 2020

BUY
$20.1 - $24.69 $348,513 - $428,099
17,339 New
17,339 $362,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $90.9M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.